This page is part of the 臺灣核心實作指引(TW Core IG) (v0.1.0: Releases) based on FHIR R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
Active as of 2014-09-19 |
{
"resourceType" : "CodeSystem",
"id" : "medcation-atc-tw",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>This code system <code>https://twcore.mohw.gov.tw/ig/twcore/CodeSystem/medcation-atc-tw</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style=\"white-space:nowrap\">A10BD27<a name=\"medcation-atc-tw-A10BD27\"> </a></td><td>metformin, linagliptin and empagliflozin</td></tr><tr><td style=\"white-space:nowrap\">A16AB22<a name=\"medcation-atc-tw-A16AB22\"> </a></td><td>avalglucosidase alfa</td></tr><tr><td style=\"white-space:nowrap\">C03DA05<a name=\"medcation-atc-tw-C03DA05\"> </a></td><td>finerenone</td></tr><tr><td style=\"white-space:nowrap\">D11AH08<a name=\"medcation-atc-tw-D11AH08\"> </a></td><td>abrocitinib</td></tr><tr><td style=\"white-space:nowrap\">G04BD14<a name=\"medcation-atc-tw-G04BD14\"> </a></td><td>imidafenacin</td></tr><tr><td style=\"white-space:nowrap\">H01BA06<a name=\"medcation-atc-tw-H01BA06\"> </a></td><td>argipressin</td></tr><tr><td style=\"white-space:nowrap\">J05AB04<a name=\"medcation-atc-tw-J05AB04\"> </a></td><td>ribavirin</td></tr><tr><td style=\"white-space:nowrap\">J05AX11<a name=\"medcation-atc-tw-J05AX11\"> </a></td><td>elvitegravir</td></tr><tr><td style=\"white-space:nowrap\">J05AX12<a name=\"medcation-atc-tw-J05AX12\"> </a></td><td>dolutegravir</td></tr><tr><td style=\"white-space:nowrap\">J05AX67<a name=\"medcation-atc-tw-J05AX67\"> </a></td><td>ombitasvir, paritaprevir and ritonavir</td></tr><tr><td style=\"white-space:nowrap\">J05AX68<a name=\"medcation-atc-tw-J05AX68\"> </a></td><td>elbasvir and grazoprevir</td></tr><tr><td style=\"white-space:nowrap\">L01FX18<a name=\"medcation-atc-tw-L01FX18\"> </a></td><td>amivantamab</td></tr><tr><td style=\"white-space:nowrap\">L01XE01<a name=\"medcation-atc-tw-L01XE01\"> </a></td><td>imatinib</td></tr><tr><td style=\"white-space:nowrap\">L01XE03<a name=\"medcation-atc-tw-L01XE03\"> </a></td><td>erlotinib</td></tr><tr><td style=\"white-space:nowrap\">L01XE06<a name=\"medcation-atc-tw-L01XE06\"> </a></td><td>dasatinib</td></tr><tr><td style=\"white-space:nowrap\">L01XE10<a name=\"medcation-atc-tw-L01XE10\"> </a></td><td>everolimus</td></tr><tr><td style=\"white-space:nowrap\">L01XE11<a name=\"medcation-atc-tw-L01XE11\"> </a></td><td>pazopanib</td></tr><tr><td style=\"white-space:nowrap\">L01XE31<a name=\"medcation-atc-tw-L01XE31\"> </a></td><td>nintedanib</td></tr><tr><td style=\"white-space:nowrap\">L01XX14<a name=\"medcation-atc-tw-L01XX14\"> </a></td><td>tretinoin</td></tr><tr><td style=\"white-space:nowrap\">L01XX17<a name=\"medcation-atc-tw-L01XX17\"> </a></td><td>topotecan</td></tr><tr><td style=\"white-space:nowrap\">L01XX19<a name=\"medcation-atc-tw-L01XX19\"> </a></td><td>irinotecan</td></tr><tr><td style=\"white-space:nowrap\">L01XX32<a name=\"medcation-atc-tw-L01XX32\"> </a></td><td>bortezomib</td></tr><tr><td style=\"white-space:nowrap\">L01XX73<a name=\"medcation-atc-tw-L01XX73\"> </a></td><td>sotorasib</td></tr><tr><td style=\"white-space:nowrap\">L04AA52<a name=\"medcation-atc-tw-L04AA52\"> </a></td><td>ofatumumab</td></tr><tr><td style=\"white-space:nowrap\">N05CM21<a name=\"medcation-atc-tw-N05CM21\"> </a></td><td>lemborexant</td></tr><tr><td style=\"white-space:nowrap\">H01AC08<a name=\"medcation-atc-tw-H01AC08\"> </a></td><td>somatrogon</td></tr><tr><td style=\"white-space:nowrap\">L01EX22<a name=\"medcation-atc-tw-L01EX22\"> </a></td><td>selpercatinib</td></tr></table></div>"
},
"url" : "https://twcore.mohw.gov.tw/ig/twcore/CodeSystem/medcation-atc-tw",
"version" : "2022-10-24",
"name" : "TWMedcationATC",
"title" : "臺灣藥品藥理治療分類ATC碼",
"status" : "active",
"experimental" : false,
"date" : "2014-09-19",
"contact" : [
{
"name" : "衛生福利部",
"telecom" : [
{
"system" : "url",
"value" : "https://www.mohw.gov.tw/"
},
{
"system" : "email",
"value" : "CCYU@mohw.gov.tw"
}
]
}
],
"description" : "臺灣藥品藥理治療分類ATC碼,參照至[https://data.gov.tw/dataset/9119](https://data.gov.tw/dataset/9119),資料提供單位:衛生福利部食品藥物管理署。 \r\n此代碼為WHO ATC(http://www.whocc.no/atc)中未涵蓋之代碼,為符合國內代碼使用,故將未被定義之代碼另外呈現。 \r\n\r\n*因原始資料無代碼版本資訊,故使用其「更新日期」作為版本資訊。*",
"copyright" : "衛生福利部食品藥物管理署",
"caseSensitive" : true,
"content" : "complete",
"count" : 27,
"concept" : [
{
"code" : "A10BD27",
"display" : "metformin, linagliptin and empagliflozin"
},
{
"code" : "A16AB22",
"display" : "avalglucosidase alfa"
},
{
"code" : "C03DA05",
"display" : "finerenone"
},
{
"code" : "D11AH08",
"display" : "abrocitinib"
},
{
"code" : "G04BD14",
"display" : "imidafenacin"
},
{
"code" : "H01BA06",
"display" : "argipressin"
},
{
"code" : "J05AB04",
"display" : "ribavirin"
},
{
"code" : "J05AX11",
"display" : "elvitegravir"
},
{
"code" : "J05AX12",
"display" : "dolutegravir"
},
{
"code" : "J05AX67",
"display" : "ombitasvir, paritaprevir and ritonavir"
},
{
"code" : "J05AX68",
"display" : "elbasvir and grazoprevir"
},
{
"code" : "L01FX18",
"display" : "amivantamab"
},
{
"code" : "L01XE01",
"display" : "imatinib"
},
{
"code" : "L01XE03",
"display" : "erlotinib"
},
{
"code" : "L01XE06",
"display" : "dasatinib"
},
{
"code" : "L01XE10",
"display" : "everolimus"
},
{
"code" : "L01XE11",
"display" : "pazopanib"
},
{
"code" : "L01XE31",
"display" : "nintedanib"
},
{
"code" : "L01XX14",
"display" : "tretinoin"
},
{
"code" : "L01XX17",
"display" : "topotecan"
},
{
"code" : "L01XX19",
"display" : "irinotecan"
},
{
"code" : "L01XX32",
"display" : "bortezomib"
},
{
"code" : "L01XX73",
"display" : "sotorasib"
},
{
"code" : "L04AA52",
"display" : "ofatumumab"
},
{
"code" : "N05CM21",
"display" : "lemborexant"
},
{
"code" : "H01AC08",
"display" : "somatrogon"
},
{
"code" : "L01EX22",
"display" : "selpercatinib"
}
]
}
IG © 2022+ 衛生福利部. Package tw.gov.mohw.twcore#0.1.0 based on FHIR 4.0.1. Generated 2023-07-05
Links: Table of Contents |
QA Report
| Version History |
Propose a change